Upstream Bio, Inc.
NASDAQ:UPBBiotechnology
+$0.10 today
- Market cap
- $114.01M
- Beta
- 1.11
- P/E (TTM)
- -2.2
- EPS (TTM)
- -$2.89
Volume 1.24M
Average 0.66M
UPB Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Upstream Bio, Inc.NASDAQ: UPB
Total Assets · Q1 FY2026 · quarter ended Mar 2026
Total assets falls 30.3% from a year ago
Total assets stood at $318.05M at the end of Q1 FY2026, down 30.3% from a year earlier and down 10.1% from the prior quarter. Over 3 fiscal years it compounded at +167.5% a year.
Context
- Total assets increased in 2 of the last 3 fiscal years.
What to watch
Whether total assets keeps falling in the next quarterly balance sheet after a -30.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 353.77M USD
- Year-over-year change
- -26.6%
- 3-year CAGR
- +167.5%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 353.77M | -26.6% |
| FY2024 | 2024-12-31 | 481.72M | +311.0% |
| FY2023 | 2023-12-31 | 117.2M | +534.3% |
| FY2022 | 2022-12-31 | 18.48M | — |
Total Assets vs competitors
How UPB compares with its peers on the latest reported figures
- Peers report in different currencies, so total assets is compared through growth and rates rather than absolute size.
- Its year-over-year change of -30.3% is the lowest of 10, against a peer median of +32.7%.
- Over three fiscal years its annual growth of +167.5% compares with a peer median of +2.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Sep 2026 | $1.1B USD | +117.9% | +121.9% | |
| Mar 2026 | $1.04B USD | -19.3% | -19.5% | |
| Jun 2026 | $967.46M USD | +32.7% | -17.3% | |
| Sep 2026 | $786.8M USD | +116.9% | -5.3% | |
| Mar 2026 | $758.78M USD | -23.1% | -17.9% | |
| Mar 2026 | $747.68M USD | +124.0% | +72.6% | |
| Mar 2026 | $583.54M USD | +102.4% | +63.4% | |
| Mar 2026 | $472.67M USD | -26.2% | +2.1% | |
UPBUpstream Bio, Inc. | Mar 2026 | $318.05M USD | -30.3% | +167.5% |
| Sep 2026 | €295.06M EUR | -12.9% | +21.6% | |
| Peer median (excluding UPB) | — | +32.7% | +2.1% | |
Competitors are the stored peer set for UPB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Upstream Bio, Inc.
NASDAQ:UPB
Intrinsic Alpha fair value
Locked
Current Price
$2.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.